Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

Novo Nordisk (NVO) stock is falling Friday morning after the pharmaceutical ... Shares of FedEx (FDX) are plummeting in after-hours trading. The shipping giant reported first quarter adjusted earnings ...

This post was written by Melanie Riehl Novo Nordisk (NVO) stock is falling Friday morning after ... Shares of FedEx (FDX) are plummeting in after-hours trading. The shipping giant reported first ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $70 ...

Hims & Hers Health to offer compounded Wegovy for $99/month to eligible military, teachers, nurses, and first responders.

Senator Sanders (I-Vt.) says CEOs of generic drugmakers are willing to sell Novo Nordisk’s (NVO) blockbuster obesity medicine ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Start your day ahead of the curve with our sharp, curated morning news roundup. Get the key stories from top newspapers and ...